MRPL40 Antibody

What is MRPL40 and what is its role in cellular function?

MRPL40, also known as NLVCF and URIM, belongs to the mitochondrion-specific ribosomal protein mL40 family. It encodes the mitochondrial ribosomal protein L40 for the larger 39S subunit of mitochondrial ribosomes . The protein has a calculated molecular weight of 24 kDa, though it is typically observed at 18-24 kDa on Western blots .

The protein is widely expressed across human tissues including heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, ovary, small intestine, colon, peripheral blood lymphocytes, and testis. Its expression in human fetuses and mouse embryos suggests a critical role in development .

What applications are MRPL40 antibodies suitable for in research?

MRPL40 antibodies can be utilized in multiple research applications, with varying levels of validation across manufacturers:

When selecting an MRPL40 antibody for your research, it's important to consider the specific validation for your application and species of interest. Different antibodies show reactivity with different species - most commonly human, with some also validated for rat samples .

What methodological considerations are important when designing experiments with MRPL40 antibodies?

When designing experiments using MRPL40 antibodies, researchers should consider:

• Protein size verification: The calculated molecular weight of MRPL40 is approximately 24 kDa, but the observed molecular weight on Western blots typically ranges from 18-24 kDa . This variation may be due to post-translational modifications, cleavage, or relative charges affecting migration patterns.

• Sample preparation: For optimal results, particularly in Western blotting, proper sample preparation is crucial. Cell or tissue lysates should be prepared with appropriate lysis buffers containing protease inhibitors to prevent degradation of the target protein.

• Controls: Positive controls (tissues/cells known to express MRPL40, such as human cell lines) and negative controls should be included to validate specificity.

• Storage conditions: MRPL40 antibodies should be stored according to manufacturer recommendations, with many requiring storage at -80°C for optimal stability and performance .

How can MRPL40 antibodies be used to investigate mitochondrial function in neurodevelopmental contexts?

MRPL40 antibodies serve as valuable tools for investigating mitochondrial function in neurodevelopmental research, particularly in the context of 22q11.2 deletion syndrome (22q11.2DS). The MRPL40 gene is one of six mitochondrial genes located in the 22q11.2 region, which when deleted predisposes individuals to multiple neurodevelopmental disorders and is a significant genetic risk factor for schizophrenia .

Methodological approaches using MRPL40 antibodies in this context include:

• Comparative protein expression analysis: Using Western blotting with MRPL40 antibodies to compare protein levels between control and experimental conditions (e.g., in models of 22q11.2DS or other neurodevelopmental disorders).

• Histological assessment: Employing immunohistochemistry or immunofluorescence with MRPL40 antibodies to visualize protein expression patterns in neural tissues, particularly focusing on neural stem and progenitor cell (NSPC) regions.

• Co-localization studies: Combining MRPL40 antibodies with markers for mitochondria, NSPCs (e.g., Sox2), and proliferation (e.g., PCNA, PH3) to investigate the relationship between mitochondrial function and neurogenesis .

Research has shown that mrpl40 mutants display significant volumetric changes in the brain, particularly in the hindbrain, which contains neuronal populations that regulate various behaviors affected in these mutants .

What are the optimal protocols for using MRPL40 antibodies in Western blot applications?

For optimal Western blot results with MRPL40 antibodies, researchers should follow these methodological recommendations:

• Sample preparation:

  • Use appropriate lysis buffers containing protease inhibitors

  • Load 25μg of protein per lane as a starting point

• Gel electrophoresis and transfer:

  • Use an appropriate percentage gel (10-12% SDS-PAGE is typically suitable for the 18-24 kDa MRPL40 protein)

  • Ensure complete transfer to membrane

• Blocking and antibody incubation:

  • Block with 3% nonfat dry milk in TBST (as used in validated protocols)

  • Use primary antibody at recommended dilution (1:500-1:2000 for most MRPL40 antibodies)

  • Incubate with appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG at 1:10000 dilution)

• Detection:

  • ECL-based detection systems have been validated for MRPL40 antibodies

  • Expect to observe bands between 18-24 kDa

An example of validated conditions is shown in the following table:

How can researchers investigate the role of MRPL40 in neural stem cell proliferation?

Research has demonstrated that MRPL40 plays a critical role in neural stem and progenitor cell (NSPC) proliferation, particularly in the dorsal proliferative zone of the hindbrain . To investigate this role, researchers can employ the following methodological approaches using MRPL40 antibodies:

• Immunofluorescence co-labeling:

  • Co-label with MRPL40 antibody and NSPC markers (Sox2)

  • Co-label with proliferation markers (PCNA, PH3)

  • Analyze the proportion of proliferating NSPCs in different brain regions

• Quantitative analysis:

  • Count the number of Sox2+/PCNA+ cells in the dorsal proliferative zone

  • Studies have shown a significant reduction in proliferative cells in the dorsal proliferative zone in mrpl40 mutants compared to wildtype

• Comparative analysis with other mitochondrial genes:

  • Analyze MRPL40 expression alongside other mitochondrial genes in the 22q11.2 region (e.g., prodha)

  • Evidence suggests that while mrpl40 and prodha mutants both show similar behavioral and brain morphology phenotypes, they function in genetically distinct pathways

  • mrpl40 appears to be particularly important for proliferation in the dorsal proliferative zone, whereas prodha affects proliferation in the central proliferative zone

What considerations are important when studying MRPL40 in models of neurodevelopmental disorders?

When studying MRPL40 in models of neurodevelopmental disorders, researchers should consider:

• Genetic interaction analysis:

  • Studies have shown that mrpl40 and prodha double mutants exhibit a more severe phenotype than either single mutant, suggesting they function in separate pathways

  • This indicates the importance of investigating potential genetic interactions between MRPL40 and other genes in the 22q11.2 region

• Functional assays:

  • Behavioral phenotyping: mrpl40 mutants show specific behavioral deficits

  • Brain morphology: Volumetric analysis reveals significant reductions in brain volume and abnormalities surrounding brain ventricles in mrpl40 mutants

  • Cellular phenotypes: Analysis of NSPC proliferation in specific brain regions

• Pharmacological validation:

  • Pharmacologic inhibition of mitochondrial function during development results in phenotypes similar to those seen in mrpl40 mutants, supporting the hypothesis that disrupted mitochondrial function contributes to the observed phenotypes

• Developmental timing:

  • The expression of MRPL40 in human fetuses and mouse embryos suggests its importance in early development

  • Researchers should consider the appropriate developmental timepoints for their studies

How can researchers troubleshoot non-specific binding when using MRPL40 antibodies?

When encountering non-specific binding with MRPL40 antibodies, researchers should consider these methodological refinements:

• Antibody selection and validation:

  • Choose antibodies that have been specifically validated for your application and species

  • Consider using recombinant antibodies which typically offer higher specificity than polyclonal antibodies

• Blocking optimization:

  • Increase blocking time or concentration (e.g., from 3% to 5% milk or BSA)

  • Try alternative blocking reagents if background persists

• Antibody dilution optimization:

  • Test a range of dilutions to find the optimal concentration that balances specific signal and background

  • For Western blot, the recommended range is 1:500-1:2000 for most MRPL40 antibodies

• Washing stringency:

  • Increase the number or duration of washes

  • Consider adding low concentrations of detergent to wash buffers

• Cross-reactivity assessment:

  • Verify specificity using knockout/knockdown controls when possible

  • Compare results across multiple antibodies targeting different epitopes of MRPL40

What are the key considerations for immunofluorescence studies of MRPL40 in neural tissues?

For successful immunofluorescence studies of MRPL40 in neural tissues, researchers should consider:

• Tissue fixation and preparation:

  • Optimal fixation methods for maintaining antigen integrity (typically 4% paraformaldehyde)

  • Appropriate antigen retrieval methods if needed for specific antibodies

• Co-labeling strategy:

  • Pair MRPL40 antibody with markers for:

    • Neural stem cells (Sox2)

    • Proliferation (PCNA, PH3)

    • Mitochondria (to confirm subcellular localization)

• Microscopy considerations:

  • Use confocal microscopy for precise co-localization studies

  • Consider super-resolution microscopy for detailed subcellular localization studies

• Quantification methods:

  • Develop consistent criteria for counting positive cells

  • Use automated image analysis when possible for unbiased quantification

  • Compare across brain regions, as MRPL40 effects may vary by region (e.g., stronger effects observed in dorsal vs. central proliferative zones)

How can MRPL40 antibodies be used to investigate 22q11.2 deletion syndrome?

MRPL40 antibodies provide valuable tools for investigating 22q11.2 deletion syndrome (22q11.2DS) through several methodological approaches:

• Expression analysis in patient-derived samples:

  • Compare MRPL40 protein levels in control vs. 22q11.2DS patient-derived cells

  • Analyze subcellular localization using immunofluorescence

• Animal model validation:

  • Use MRPL40 antibodies to confirm protein reduction in 22q11.2DS animal models

  • Compare expression patterns across different brain regions and developmental stages

• Mechanistic studies:

  • Investigate the relationship between MRPL40 deficiency and mitochondrial translation

  • Assess downstream effects on electron transport chain component levels

  • Examine consequences for neural stem cell proliferation and differentiation

Research has shown that microdeletion of the 22q11.2 region, which contains MRPL40 and 44 other protein-coding genes, predisposes to multiple neurodevelopmental disorders and is one of the greatest genetic risk factors for schizophrenia .

What is the current understanding of MRPL40's role in neurodevelopmental disorders?

Current research indicates several key roles for MRPL40 in neurodevelopmental processes:

• Neural stem cell regulation:

  • MRPL40 is required for normal neural stem and progenitor cell (NSPC) proliferation

  • It appears to specifically regulate proliferation in the dorsal proliferative zone of the hindbrain

  • Loss of MRPL40 results in reduced numbers of proliferative cells in this region

• Brain development:

  • mrpl40 mutants display significant reductions in brain volume

  • Abnormalities are observed surrounding brain ventricles, where NSPCs reside

• Mitochondrial function in neurodevelopment:

  • As a component of the mitochondrial ribosome, MRPL40 is essential for mitochondrial translation

  • Disruption of MRPL40 function leads to decreased mitochondrial protein synthesis

  • Pharmacologic inhibition of mitochondrial function during development phenocopies the mrpl40 mutant phenotype

• Behavioral outcomes:

  • mrpl40 mutants exhibit specific behavioral phenotypes

  • These behaviors relate to functions regulated by hindbrain neuronal populations

These findings suggest that MRPL40 deficiency contributes to the neurodevelopmental phenotypes observed in 22q11.2DS through its effects on mitochondrial function and neural stem cell proliferation.

What emerging techniques might enhance MRPL40 antibody-based research?

Several emerging techniques hold promise for advancing MRPL40 antibody-based research:

• Proximity labeling methods:

  • BioID or APEX2-based approaches to identify proteins in close proximity to MRPL40

  • These methods could reveal novel interaction partners within the mitochondrial ribosome or unexpected extra-mitochondrial interactions

• Live-cell imaging:

  • Development of fluorescently-tagged nanobodies against MRPL40 for live-cell tracking

  • This would allow real-time visualization of MRPL40 dynamics in living cells and tissues

• Single-cell proteomics:

  • Application of emerging single-cell proteomics techniques to analyze MRPL40 expression at the single-cell level

  • This would reveal cell-to-cell variation in MRPL40 expression within heterogeneous neural populations

• Spatial transcriptomics integration:

  • Combining MRPL40 antibody-based immunohistochemistry with spatial transcriptomics

  • This integrated approach would provide insights into how MRPL40 protein expression correlates with transcriptional profiles across brain regions

These techniques would provide deeper insights into MRPL40 function in neural development and potentially identify new therapeutic targets for neurodevelopmental disorders associated with 22q11.2DS.

What are the methodological challenges in studying MRPL40 interactions with other mitochondrial genes?

Studying interactions between MRPL40 and other mitochondrial genes presents several methodological challenges:

Addressing these challenges requires multidisciplinary approaches combining genetics, cell biology, biochemistry, and advanced imaging techniques.